Safer Minimally Invasive Treatments in High-Risk & Comorbid Patients with Prostate Enlargement (BPH)
Prostate enlargement, which is called Benign Prostatic Hyperplasia (BPH) is a non-cancerous enlargement and is common in ...
King Harald of Norway is "responding well" to treatment and is set to be discharged from hospital after being taken ill while holidaying overseas. The monarch, who marked his 89th birthday over the ...
Boston Scientific announced multiple recalls but has said its battery issues were limited. One internal test in 2025 found ...
Nurse-led bladder volume support improved radiotherapy reproducibility and reduced repeat imaging in prostate cancer. Read ...
For years, Susan Johnstone, 53, lived with an embarrassing problem that threatened to take away the activity she loved most: ...
As a potential biomarker of treatment response, ctDNA and utDNA analyses were performed before systemic therapy, at restaging, and for responders at the beginning of adjuvant nivolumab. ctDNA was ...
A prospective, multicenter phase 2 trial evaluated the safety of neoadjuvant radiation plus immunotherapy before radical cystectomy for bladder cancer.
After partnering with Depend last year following his bladder cancer surgery, Colorado head coach Deion Sanders brought his story to life in his first commercial for the company. Sanders starred in ...
Researchers at the Icahn School of Medicine at Mount Sinai have reported promising findings that may help redefine treatment for patients with muscle-invasive bladder cancer, a potentially aggressive ...
In a meeting between a biologist and a urologist, one question kept returning: why do so many bladder cancer patients face recurrence even after surgery that follows every guideline? The initiative ...
President Trump slammed the investigation into Nancy Guthrie’s disappearance Thursday, but told reporters it’s time to pay attention to“other subjects” after weeks of national fixation on the apparent ...
Fox Chase Cancer Center researchers reported positive results from the trial, known as RETAIN-2, demonstrating that a response-adapted bladder-preservation approach involving neoadjuvant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results